ArticleEuropean journal of preventive cardiology2024

Genetically proxied low-density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations.

Maddalena Ardissino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.